Editor’s note: This is an automatically generated transcript Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So I think the most important one is the ...
While most potassium-competitive acid blockers demonstrate superior healing rates than proton pump inhibitors (PPIs) in patients with erosive esophagitis, both types of treatment offer relief compared ...
The treatment of Helicobacter pylori (H. pylori) infection remains a challenge due to the increasing prevalence of drug-resistant bacteria. It is hypothesized that using more potent acid suppressants, ...
Concomitant use of potassium-competitive acid blockers (P-CABs) or proton pump inhibitors (PPI) with clopidogrel was associated with an increased risk for major adverse cardiovascular events (MACEs) ...
VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available through major retail pharmacies and BlinkRx, an end-to-end digital fulfillment channel VOQUEZNA ...
The U.S. Food and Drug Administration has approved Phathom Pharmaceuticals' Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of ...
Hosted on MSN
Do acid blockers affect gut health?
Every time you feel heartburn or the slightest discomfort in your body between your trachea and stomach, you tend to label it as acidity and pop one of the easily available over-the-counter acid ...
Colin Howden, MD, discusses the mechanisms at work in vonoprazan as well as patient monitoring and potential future uses following a recent FDA approval for the treatment of erosive esophagitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results